Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
12/2013
12/26/2013US20130343988 Pyrido [2, 3-D] pyrimidin-7-one compounds as inhibitors of P13K-Alpha for the treament of cancer
12/25/2013EP2676678A1 Methods to identify and enrich populations of ovarian cancer stem cells and somatic stem cells and uses thereof
12/25/2013EP2676664A1 Potentiator of antitumor activity of chemotherapeutic agent
12/25/2013EP2675455A2 Ophthalmic composition for enabling dilation of pupils
12/25/2013EP2675451A1 mTOR/JAK INHIBITOR COMBINATION THERAPY
12/25/2013EP2675450A1 Combinations of therapeutic agents for use in the treatment of neurodegenerative diseases
12/25/2013EP2675446A1 Omega 3 formulations comprising epa, dha and dpa for treatment of risk factors for cardiovascular disease
12/25/2013EP2675445A1 Statin and omega 3 fatty acids (epa, dha and dpa) for use in cardiovascular diseases
12/25/2013EP2675444A1 A formulations comprising omega 3 fatty acids and an anti obesity agent for the reduction of body weight in cardiovascular disease patients (cvd) and diabetics
12/25/2013EP2675443A1 Omega 3 fatty acid diagniostic assay for the dietary management of patients with cardiovascular disease (cvd)
12/25/2013EP2675442A1 Cholesterol absorption inhibitor (azetidinone) and omega 3 fatty acids (epa, dha, dpa) for the reduction of cholesterol and for the reduction of cardiovascular events
12/25/2013EP2503999B1 Pharmaceutical composition comprising propofol
12/25/2013EP2416794B1 Plant composition for the treatment or prevention of viral blood-borne diseases caused by the human immunodeficiency virus (hiv) or hepatitis c
12/25/2013EP2269589B1 Ion binding polymers and uses thereof
12/25/2013EP2214683B9 Unit dosage for brain health
12/25/2013CN103476433A Improved immunotherapy
12/25/2013CN103476405A Therapeutic agent for diastolic congestive heart failure
12/25/2013CN103463646A Application of E2F1 protein in preparation of medicine for diagnosing and treating osteosarcoma
12/25/2013CN103463635A Ophthalmic compositions comprising povidone-iodine
12/25/2013CN103463619A Application of bone morphogenetic protein 4 in cancer inhibition
12/25/2013CN103463096A Fast acting inhibitor of gastric acid secretion
12/25/2013CN103462923A Double layer sustained release tablet for treatment of hyperlipidemia
12/25/2013CN102049048B Method of treatment or prophylaxis
12/24/2013US8614330 Substituted benz-azoles and methods of their use as inhibitors of RAF kinase
12/24/2013US8613914 Peptidomimetic sulfamide compounds and antiviral uses thereof
12/24/2013US8613903 Humanized L243 antibodies
12/24/2013CA2759936C Oral compositions for skin benefits
12/24/2013CA2641546C Therapeutic agent for inflammatory bowel disease containing as active ingredient 2-amino-1,3-propanediol derivative, or method for treating inflammatory bowel disease
12/24/2013CA2561146C 1-benzoyl-4-[2-[4-methoxy-7-(3-methyl-1h-1,2,4-triazol-1-yl)-1h-pyrrolo[2-,3-c]pyridin-3-yl]-1,2-dioxoethyl]-piperazine for use in treating hiv infection
12/24/2013CA2485988C Methods of modulating tubulin deacetylase activity
12/24/2013CA2457461C Complement pathway inhibitors binding to c5 and c5a without preventing the formation of c5b
12/24/2013CA2375104C Prevention and treatment of amyloidogenic disease
12/19/2013WO2013188763A1 Compositions for treating cancer and methods for making the same
12/19/2013WO2013188529A1 Use of isolated bacterial amyloids for treatment of inflammatory disorders or diseases of the epithelium
12/19/2013WO2013188417A2 Treatment and prevention of cardiovascular disease and thrombosis
12/19/2013WO2013187891A1 Method for treating a pulmonary disease state in mammals by up regulating indigenous in vivo levels of inflammatory agents in mammalian cells
12/19/2013WO2013187052A1 Anti-colon cancer agent
12/19/2013WO2013186399A1 V1b receptor antagonist for use in the treatment of patients having an elevated avp level and/or an elevated copeptin level
12/19/2013WO2013186220A1 Compositions comprising hesperidin and/or apigenin i.a. for medical use or for use in treatment of sleeping disorders
12/19/2013WO2013185764A2 Pharmaceutical compositions for combination therapy
12/19/2013US20130340102 Humanized antibodies to ca215
12/19/2013US20130338225 Compounds As L-Cystine Crystallization Inhibitors And Uses Thereof
12/19/2013US20130338217 Antibiotic composition including phlorotannin compound derived from eisenia bicyclis as effective component
12/19/2013US20130338209 Treatment for lipodystrophy
12/19/2013US20130338203 TREATMENT OF ARTERIAL AGEING BY COMBINATION OF RAAS INHIBITOR AND HMG-CoA REDUCTASE INHIBITOR
12/19/2013US20130338201 Method of Cancer Treatment with 2-(1H-Indole-3-Carbonyl)-Thiazole-4-Carboxylic Acid Methyl Ester
12/19/2013US20130338196 Alpha-ketoheterocycles and methods of making and using
12/19/2013US20130338192 Method for augmenting the effects of serotonin reuptake inhibitors
12/19/2013US20130338185 1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
12/19/2013US20130338176 Methods of preventing and treating hyperlipidemia or atherosclerosis
12/19/2013US20130338172 Crystalline forms of a bruton's tyrosine kinase inhibitor
12/19/2013US20130338164 Multimeric VLA-4 Antagonists Comprising Polymers Moieties
12/19/2013US20130338163 Vinyl-aryl derivatives for inflammation and immune-related uses
12/19/2013US20130338161 Axl inhibitors for use in combination therapy for preventing, treating or managing metastatic cancer
12/19/2013US20130338159 Bi-heteroaryl compounds as vps34 inhibitors
12/19/2013US20130338155 Method for treating infections
12/19/2013US20130338154 Mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
12/19/2013US20130338152 Fluorophenyl bicyclic heteroaryl compounds
12/19/2013US20130338140 Serine/threonine kinase inhibitors
12/19/2013US20130338138 Azetidine and piperidine compounds useful as pde10 inhibitors
12/19/2013US20130338137 Substituted annellated pyrimidines and use thereof
12/19/2013US20130338133 Substituted imidazopyridazines
12/19/2013US20130338124 Organic compounds
12/19/2013US20130338118 Compounds for treatment of heart failure
12/19/2013US20130338113 Materials and methods for treating viral infections
12/19/2013US20130338111 Sulfonamide Derivatives
12/19/2013US20130338103 Treatment of cancer
12/19/2013US20130338100 Method of Cross-Linking Hyaluronic Acid with Divinylsulfone
12/19/2013US20130338099 Mercapto-modified biocompatible macromolecule derivatives with low degree of mercapto-modification and the cross-linked materials and uses thereof
12/19/2013US20130338093 Bile Acid Recycling Inhibitors for Treatment of Pediatric Cholestatic Liver Diseases
12/19/2013US20130338081 Iap antagonists
12/19/2013US20130338080 Compositions and methods for treating an activated b-cell diffuse large b-cell lymphoma
12/19/2013US20130338071 GLP-1 Agonist and Cardiovascular Complications
12/19/2013US20130338066 Novel substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof
12/19/2013US20130338062 Hcv protease inhibitors and uses thereof
12/19/2013US20130337549 Materials and methods for nerve grafting
12/19/2013US20130337094 Nutritional Supplement Comprising Nut and Seed Oil Composition
12/19/2013US20130337090 Plant extracts for treating burns and chronic wounds
12/19/2013US20130337075 Nanomedicines for early nerve repair
12/19/2013US20130337066 Membrane Encapsulated Nanoparticles and Method of Use
12/19/2013US20130337055 Compositions, methods of treatment and diagnostics for treatment of hepatic steatosis alone or in combination with a hepatitis c virus infection
12/19/2013US20130337054 Treatment of excessive menstrual blood loss by intravaginal administration of low doses of antifibrinolytic or hemostatic agent
12/19/2013US20130337053 Novel formulations and methods
12/19/2013US20130337042 Use of PVP-Iodine Liposomes for Treatment of Herpes
12/19/2013US20130337039 Internalizing ErBB2 Antibodies
12/19/2013US20130337015 C-Met Modulator Pharmaceutical Compositions
12/19/2013US20130337012 Tissue Targeted Antigenic Activation of the Immune Response to Treat Cancers
12/19/2013US20130336998 Vaccination in newborns and infants
12/19/2013US20130336976 Human immune therapies using a cd27 agonist alone or in combination with other immune modulators
12/19/2013US20130336970 Compositions and Methods for Treating and Diagnosing Cancer
12/19/2013US20130336965 Novel ring-substituted n-pyridinyl amides as kinase inhibitors
12/19/2013US20130336962 Aziridine bisphenol ethers and related compounds and methods for their use
12/19/2013US20130336960 Method to identify a patient with an increased likelihood of responding to an anti-cancer therapy
12/19/2013US20130336959 Method to identify a patient with an increased likelihood of responding to an anti-cancer therapy
12/19/2013US20130336949 Tetrazole compounds for reducing uric acid
12/19/2013US20130336942 Use of a probiotic to regulate body weight
12/19/2013US20130336938 Transplantation of cells into the nasal cavity and the subarachnoid cranial space
12/19/2013US20130336922 Hla-binding peptides derived from prostate-associated antigenic molecules and methods of use thereof
12/19/2013US20130336921 Compounds and methods for inhibiting phosphate transport
12/19/2013US20130336920 Compounds and methods for inhibiting phosphate transport
1 ... 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 ... 1151